Pharmaceutical composition containing pyridyl glycine compound
A technology of composition and base amino, which is applied in the field of stabilizing the compound or its salt, can solve the problems that there is no record, and there is no record of the preservation effect of the pharmaceutical composition, so as to achieve sufficient safety, improve the preservation effect, and excellent preservation effect Effect
Active Publication Date: 2020-06-02
SANTEN PHARMA CO LTD
View PDF3 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0005] However, there is no description containing isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate or its salt, and containing ethylenediamine tetraacetic acid or its salt of the pharmaceutical composition, in addition, for improving (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-yl) in the pharmaceutical composition There is no record about the stability of isopropyl sulfonyl)aminomethyl}pyridin-2-ylamino)acetate or its salts and the preservation efficacy of pharmaceutical compositions
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0066] Preparation examples and test results are shown below, but these preparation examples and test results are for better understanding of the present invention and do not limit the scope of the present invention.
[0067] Preparation example
[0068] Representative formulation examples using this compound are shown below. In addition, in the following formulation examples, the compounding quantity of each component is the content in 100 mL of compositions.
preparation example 1
[0070] Eye drops (in 100mL)
[0071]
preparation example 2
[0073] Eye drops (in 100mL)
[0074]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The object of the present invention is to provide: a pharmaceutical composition containing the compound, the compound in the pharmaceutical composition is stable, and the pharmaceutical composition has excellent preservation effect; The method of the stability and preservation potency of pharmaceutical composition. The pharmaceutical composition involved in the present invention contains (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate isopropyl or a salt thereof, and ethylenediaminetetraacetic acid or a salt thereof.
Description
technical field [0001] The present invention relates to a compound containing (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate or its salt A pharmaceutical composition, and a method for stabilizing the compound or a salt thereof. Background technique [0002] (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate isopropyl is represented by the following formula (1) compound. [0003] [0004] Patent Document 1 and Patent Document 2 describe (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetic acid iso Pyridyl glycine compounds such as propyl ester, Patent Document 1 describes a preparation example containing concentrated glycerin and polysorbate 80 as eye drops of pyridyl glycine compounds. [0005] However, there is no description containing isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate or its salt, and contain...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K31/444A61K9/08A61K47/04A61K47/12A61K47/18A61K47/22A61K47/32A61P9/12A61P27/02A61P27/06
CPCA61K47/12A61K47/22A61K31/444A61K9/0048A61K47/02A61K47/26A61K47/44A61K47/183A61P27/02A61P27/06A61P9/12Y02A50/30
Inventor 远藤洋子
Owner SANTEN PHARMA CO LTD
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
